<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: <z:chebi fb="0" ids="4031">Cyclosporine</z:chebi>-A (CSA) combined with <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> therapy was administered to 12 patients with severe <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's <z:hpo ids='HP_0000554'>uveitis</z:hpo> who were resistant to <z:chebi fb="0" ids="23359">colchicine</z:chebi> or cytotoxic therapy </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Previous <z:chebi fb="0" ids="23359">colchicine</z:chebi> or cytotoxic therapies were tapered off one month before CSA therapy </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were started on an initial oral dose of 5 mg/kg/day of CSA </plain></SENT>
<SENT sid="3" pm="."><plain>After the first three months, the CSA dose was reduced to a maintenance dose according to the intraocular <z:mp ids='MP_0001845'>inflammatory response</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The average follow-up period was 20 (12-36) months </plain></SENT>
<SENT sid="5" pm="."><plain>Visual acuity remained the same in 12 (%54.5) and improved in 8 (%36.4) eyes </plain></SENT>
<SENT sid="6" pm="."><plain>There was a decrease in the frequency (p&lt;0.01) and severity (p&lt;0.01) of ocular attacks and in the maintenance steroid dose (p&lt;0.01) when compared with conventional therapy </plain></SENT>
<SENT sid="7" pm="."><plain>The frequent side effects were paraesthesia-<z:hpo ids='HP_0100963'>hyperesthesia</z:hpo>, <z:mp ids='MP_0002899'>fatigue</z:mp>, <z:hpo ids='HP_0002018'>nausea</z:hpo>, <z:hpo ids='HP_0001007'>hirsutism</z:hpo> and dose-related nephrotoxicity in one patient </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: The results of the study suggest that low dose CSA combined with low dose <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> may be an effective therapeutic alternative in the treatment of severe refractory <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's <z:hpo ids='HP_0000554'>uveitis</z:hpo> </plain></SENT>
</text></document>